Literature DB >> 11283109

Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.

J Iwahashi1, K Tsuji, T Ishibashi, J Kajiwara, Y Imamura, R Mori, K Hara, T Kashiwagi, Y Ohtsu, N Hamada, H Maeda, M Toyoda, T Toyoda.   

Abstract

In Japan, the use of amantadine for treatment of influenza A virus infection was not accepted until November 1998, although it was widely used for treatment of Parkinsonism. Since then, we have monitored the emergence of amantadine-resistant viruses and isolated two viruses from patients on long-term treatment with amantadine.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11283109      PMCID： PMC87992          DOI： 10.1128/JCM.39.4.000-000.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

Authors:  E E Mast; M W Harmon; S Gravenstein; S P Wu; N H Arden; R Circo; G Tyszka; A P Kendal; J P Davis
Journal:  Am J Epidemiol       Date:  1991-11-01       Impact factor: 4.897

Review 2.  Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.

Authors:  R L Tominack; F G Hayden
Journal:  Infect Dis Clin North Am       Date:  1987-06       Impact factor: 5.982

3.  Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A.

Authors:  P D Reuman; D I Bernstein; M C Keefer; E C Young; J R Sherwood; G M Schiff
Journal:  Antiviral Res       Date:  1989-02       Impact factor: 5.970

4.  A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.

Authors:  R Dolin; R C Reichman; H P Madore; R Maynard; P N Linton; J Webber-Jones
Journal:  N Engl J Med       Date:  1982-09-02       Impact factor: 91.245

Review 5.  Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine.

Authors:  F G Hayden; A J Hay
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

6.  Biologic potential of amantadine-resistant influenza A virus in an avian model.

Authors:  W J Bean; S C Threlkeld; R G Webster
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

7.  Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.

Authors:  F G Hayden; S J Sperber; R B Belshe; R D Clover; A J Hay; S Pyke
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Amantadine-resistant influenza A in a nursing facility.

Authors:  J Degelau; S K Somani; S L Cooper; D R Guay; K B Crossley
Journal:  Arch Intern Med       Date:  1992-02

9.  Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.

Authors:  F G Hayden; R B Belshe; R D Clover; A J Hay; M G Oakes; W Soo
Journal:  N Engl J Med       Date:  1989-12-21       Impact factor: 91.245

10.  Direct determination of adamantanamine in plasma and urine with automated solid phase derivatization.

Authors:  F X Zhou; I S Krull; B Feibush
Journal:  J Chromatogr       Date:  1993-09-08
View more
  7 in total

Review 1.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

Review 2.  Influenza: emergence and control.

Authors:  Aleksandr S Lipatov; Elena A Govorkova; Richard J Webby; Hiroichi Ozaki; Malik Peiris; Yi Guan; Leo Poon; Robert G Webster
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.

Authors:  Yanmei Hu; Rami Musharrafieh; Chunlong Ma; Jiantao Zhang; Donald F Smee; William F DeGrado; Jun Wang
Journal:  Antiviral Res       Date:  2017-01-10       Impact factor: 5.970

4.  Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication.

Authors:  Andrew Lutz; Julie Dyall; Paul D Olivo; Andrew Pekosz
Journal:  J Virol Methods       Date:  2005-06       Impact factor: 2.014

5.  Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.

Authors:  Brenda L Fredericksen; Bangdong L Wei; Jian Yao; Tianci Luo; J Victor Garcia
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 6.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

7.  Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea.

Authors:  Jiyeon Lee; Young Jun Song; Jeung Hyun Park; Jun-Han Lee; Yun Hee Baek; Min-Suk Song; Taek-Kyu Oh; Heon-Seok Han; Philippe Noriel Q Pascua; Young-Ki Choi
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.